tiprankstipranks
Trending News
More News >
Gossamer Bio Inc (GOSS)
NASDAQ:GOSS
US Market

Gossamer Bio (GOSS) Income Statement

Compare
1,185 Followers

Gossamer Bio Income Statement

Last quarter (Q3 2025), Gossamer Bio's total revenue was $13.29M, an increase of 40.23% from the same quarter last year. In Q3, Gossamer Bio's net income was $-48.22M. See Gossamer Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 114.70M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 114.70M$ 0.00$ 0.00$ 0.00$ -4.27M
Operating Expenses
$ 174.62M$ 183.76M$ 218.59M$ 216.12M$ 206.31M
Depreciation and Amortization
$ 4.15M$ 4.38M$ 4.43M$ 5.17M$ 4.27M
EBITDA
$ -39.97M$ -161.92M$ -211.07M$ -209.40M$ -226.43M
Operating Income
$ -59.92M$ -183.76M$ -218.59M$ -216.12M$ -210.58M
Other Income/Expenses
$ 4.28M$ 3.94M$ -10.79M$ -17.88M$ -32.78M
Pretax Income
$ -55.63M$ -179.82M$ -229.38M$ -234.00M$ -243.36M
Net Income
$ -56.53M$ -179.82M$ -229.38M$ -234.00M$ -243.36M
Per Share Metrics
Basic EPS
$ -0.25$ -0.80$ -2.84$ -3.33$ -3.67
Diluted EPS
$ -0.25$ -1.18$ -2.84$ -3.33$ -3.67
Weighted Average Shares Outstanding
226.23M 225.57M 84.57M 74.84M 68.51M
Weighted Average Shares Outstanding (Diluted)
226.23M 225.57M 84.57M 74.84M 68.51M
Currency in USD

Gossamer Bio Earnings and Revenue History